Clinical trial
Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions
NCT01712100
Study timeline
Study start (unknown)2007-08-01Date precision: month
Registry last updated2018-01-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Interventions
IrbesartanDRUG · verified · RxNorm: irbesartan
AvaproDRUG · verified · RxNorm: Avapro
Sponsors & collaborators
Roxane Laboratorieslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01712100 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.